Related Experiment Video

Updated: May 21, 2026

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

RAP1GAP inhibits cytoskeletal remodeling and motility in thyroid cancer cells

Xiaoyun Dong1, Waixing Tang, Stephen Stopenski

  • 1Department of Pharmacology - Head and Neck Surgery, School of Medicine, University of Pennsylvania, 421 Curie Boulevard, BRB II/III, Philadelphia, PA 19104, USA.

Endocrine-Related Cancer
|June 15, 2012
PubMed

Insights

Downregulation of RAP1GAP protein in thyroid tumors enhances SRC activity, leading to increased cell migration and altered cellular architecture. This suggests SRC is a key target of RAP1GAP depletion in thyroid cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Decreased RAP1GAP protein expression is observed in human tumors, but its functional significance, particularly in thyroid cancer, remains unclear.
  • RAP1GAP regulates cell adhesion and migration, and its downregulation may impact tumor progression by affecting downstream signaling pathways.

Purpose of the Study:

  • To investigate the role of RAP1GAP downregulation in thyroid tumors.
  • To identify downstream targets of RAP1GAP in thyroid cancer cells.
  • To elucidate the functional consequences of RAP1GAP depletion on cell behavior and signaling.

Main Methods:

  • Analysis of RAP1 and RAP2 protein expression in normal thyroid cells and primary thyroid tumors.
  • Transient expression of RAP1GAP in thyroid carcinoma cell lines to assess its effects on cell spreading and migration.
  • Investigation of protein tyrosine phosphorylation and SRC kinase activity in response to RAP1GAP modulation.

Main Results:

  • RAP1GAP and RAP2 were co-expressed in normal thyroid cells, while RAP1 was detected in papillary thyroid carcinomas alongside RAP2.
  • RAP1GAP expression inhibited cell spreading and migration on collagen in thyroid cancer cell lines.
  • RAP1GAP impaired SRC-dependent phosphorylation of focal adhesion kinase and paxillin, and inhibited SRC activity.

Conclusions:

  • SRC is identified as a direct target of RAP1GAP depletion in thyroid tumors.
  • Downregulation of RAP1GAP in thyroid tumors promotes SRC-dependent signaling, enhancing cellular motility and potentially contributing to tumor progression.
  • These findings highlight a novel mechanism involving RAP1GAP and SRC in thyroid cancer pathogenesis.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.